Cristina Moglia

Country flagItaly

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (5)

Background and purpose Thalamic alterations have been reported as a major feature in presymptomatic and symptomatic patients carrying the C9orf72 mutation across the frontotemporal dementia–amyotrophic lateral sclerosis (ALS) spectrum. Specifically, the pulvinar, a high‐order thalamic nucleus and timekeeper for large‐scale cortical networks, has been hypothesized to be involved in C9orf72 ‐related neurodegenerative diseases. We investigated whether pulvinar volume can be useful for differential diagnosis in ALS C9orf72 mutation carriers and noncarriers and how underlying functional connectivity changes affect this region. Methods We studied 19 ALS C9orf72 mutation carriers ( ALSC9+ ) accurately matched with wild‐type ALS ( ALSC9 −) and ALS mimic ( ALSmimic ) patients using structural and resting‐state functional magnetic resonance imaging data. Pulvinar volume was computed using automatic segmentation. Seed‐to‐voxel functional connectivity analyses were performed using seeds from a pulvinar functional parcellation. Results Pulvinar structural integrity had high discriminative values for ALSC9+ patients compared to ALSmimic (area under the curve [AUC] = 0.86) and ALSC9 − (AUC = 0.77) patients, yielding a volume cutpoint of approximately 0.23%. Compared to ALSmimic , ALSC9 − showed increased anterior, inferior, and lateral pulvinar connections with bilateral occipital–temporal–parietal regions, whereas ALSC9+ showed no differences. ALSC9+ patients when compared to ALSC9 − patients showed reduced pulvinar–occipital connectivity for anterior and inferior pulvinar seeds. Conclusions Pulvinar volume could be a differential biomarker closely related to the C9orf72 mutation. A pulvinar–cortical circuit dysfunction might play a critical role in disease progression and development, in both the genetic phenotype and ALS wild‐type patients.

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2020

Collaborators (12)

Francesca Luisa Conforti

Associate Professor in Medical Genetics

University of Calabria

ITALY
View details

Nilo Riva

-

ITALY
View details

Andrea CALVO

MD, PhD, Associate Professor of Neurology

Università degli Studi di Torino

ITALY
View details

Jean Paul Medina Carrion

Fondazione IRCCS Istituto Neurologico Carlo Besta

ITALY
View details

Silvestro Roatta

University of Turin

ITALY
View details

Paolo Volanti

Head

Istituti Clinici Scientifici Maugeri SpA IRCCS Lumezzane

ITALY
View details

Umberto Manera

University of Turin

ITALY
View details

Paola Mandich

University of Genoa

ITALY
View details

Marcella Zollino

Università Cattolica del Sacro Cuore

ITALY
View details

Federica Agosta

-

ITALY
View details

Adriano Chio

Professor of Neurology

University of Turin

ITALY
View details

Alessandro Bombaci

Assistant Professor

Vita-Salute San Raffaele University

ITALY
View details
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.